We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Settles FCPA Charges; Sees Leniency Thanks to Proactive Compliance Steps
Pfizer Settles FCPA Charges; Sees Leniency Thanks to Proactive Compliance Steps
August 10, 2012
Pfizer will pay $60 million to resolve Foreign Corrupt Practices Act charges, but its proactive corporate compliance program allowed it to avoid even harsher penalties — including imposition of an outside corporate monitor.